Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bassoon presynaptic cytomatrix protein (BSN) is a large scaffolding protein located at the presynaptic active zone of neurons where neurotransmitter release occurs[1][6]. It organizes the cytomatrix underlying the plasma membrane and ensures proper spatial arrangement of synaptic vesicle clusters and other protein complexes critical for synaptic vesicle fusion and endocytosis[1][2][6]. BSN is primarily expressed in the brain, is highly concentrated at active zones, and is essential for regulating neurotransmitter release. It interacts with other cytomatrix proteins and contributes to synaptic targeting, assembly of the active zone, and communication from synapse to nucleus, modulating gene expression and presynaptic autophagy. Mutations or dysfunctions in this protein have been associated with epilepsy and autism spectrum disorder[1]. No drugs are known to directly target this protein, nor is it considered a therapeutic target in current pharmacology, but it plays a crucial structural and regulatory role in neuronal function[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bassoon presynaptic cytomatrix protein (BSN).